Additionally, it has been evident that engineered co-expression of CAR and C-C chemokine receptor 4 (CCR4) by effector T cells can result in enhanced tumor-site trafficking and tumoricidal cytotoxicity (89). Here, CCR4 is linked to neoplasm.